IL1B and allergic disease: In their study conducted in Ulsan of Korea, Han et al. identified IL-1β as a strong risk factor for developing moderate to severe, persistent AR, thus, highlighting that it could be employed as a biomarker for the exacerbation or activation of allergic diseases [85].